Airain Ltd’s ResMed RMD Stock Holding History

Airain Ltd’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-17,258	Closed	-$1.24M	–	1013
2017 Q1	$1.24M	Buy	+17,258	New	+$1.19M	0.06%	304
2016 Q4	–	Sell	-24,890	Closed	-$1.61M	–	825
2016 Q3	$1.61M	Sell	24,890 -29,543	-54%	-$1.97M	0.1%	255
2016 Q2	$3.44M	Buy	+54,433	New	+$3.21M	0.2%	147
2016 Q1	–	Sell	-46,559	Closed	-$2.5M	–	1023
2015 Q4	$2.5M	Buy	+46,559	New	+$2.62M	0.17%	158
2014 Q4	–	Sell	-4,068	Closed	-$200K	–	883
2014 Q3	$200K	Buy	+4,068	New	+$207K	0.01%	680
2014 Q2	–	Sell	-32,611	Closed	-$1.46M	–	899
2014 Q1	$1.46M	Sell	32,611 -7,407	-19%	-$333K	0.26%	126
2013 Q4	$1.88M	Buy	+40,018	New	+$2.03M	0.24%	110

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Airain Ltd's RMD Position: Q2 2017 in Review

Airain Ltd sold out of ResMed (RMD) in Q2 2017, closing a stake of 17,258 shares — an estimated $1.24M sold.

Airain Ltd first reported a position in RMD in Q4 2013 and held it in 7 quarters. The position peaked at $3.44M in Q2 2016. 339 funds tracked by Wall St. Rank hold RMD as of Q2 2017.

Airain Ltd reported no remaining ResMed position as of Q2 2017 after selling out during the quarter.
Airain Ltd sold 17,258 ResMed shares in Q2 2017, an estimated $1.24M.
Airain Ltd first reported a position in ResMed in Q4 2013 and held it in 7 quarters.
Airain Ltd's ResMed position peaked at $3.44M in Q2 2016.
339 funds tracked by Wall St. Rank held ResMed as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.